# Ethicon, Inc.: Not applicable (device, behavioral) study completed, 108 enrolled (Hemostasis, Hemostatic Techniques)

**Score:** 85/100

| Field | Value |
|---|---|
| Sponsor | Ethicon, Inc. |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery |
| NCT ID | NCT06664788 |
| Phase | Not applicable (device, behavioral) |
| Status | completed |
| Conditions | Hemostasis; Hemostatic Techniques |
| Intervention types | device |
| Target enrollment | 108 |
| Site countries | United States, Netherlands |
| Posted | 2024-10-30 |
| Planned start | 2025-04-16 |
| Event | Completed |
| Event date | 2026-10-07 |
| Last update posted | 2026-11-03 |

## Why this score
- Posted in the last two weeks.
- Industry sponsor (buys outsourced services).
- Completed: closeout, analysis and the next study ahead.
- 108 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT06664788). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.